Increased YAP1 promotes resistance to RAF (Raf-1 proto-oncogene) or mitogen-activated protein kinase kinases inhibitor therapy through transcription active of an anti-apoptotic protein BCL2 like 1 in many types of tumor cells20. The gene discussed is YAP1; the disease is neoplasm.